Mietintö Theodoros Zagorakisin koskemattomuuden pidättämistä koskevasta pyynnöstä (II) (2015/2071(IMM)) — JURI-valiokunta — Esittelijä: Andrzej Duda (A8-0151/2015)
Our research program involves the following milestones: 1. identification of susceptibility genes using candidate-gene and gene-expression profile-basedapproaches;2. evaluation of the clinical predictive value of the susceptibility genes; 3. investigation of the impact of the susceptibility genes on the determinants of adoption of healthy behaviors and 4. integration of genetic information into primary and secondary prevention strategies.EurLex-2 EurLex-2